logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Muhammad, Ado Hadejia, Dr
    Born in October 1965
    Individual (7 offsprings)
    Officer
    icon of calendar 2019-09-09 ~ now
    OF - Director → CIF 0
    Dr Ado Hadejia Muhammad
    Born in October 1965
    Individual (7 offsprings)
    Person with significant control
    icon of calendar 2019-09-09 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

PHARMEDAS CLINICAL LTD

Previous name
PHARMEDAS CLINCAL LTD - 2021-05-31
Standard Industrial Classification
86900 - Other Human Health Activities
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
23,616 GBP2024-09-30
2,676 GBP2023-09-30
Cash at bank and in hand
30,429 GBP2024-09-30
44,997 GBP2023-09-30
Current Assets
54,045 GBP2024-09-30
47,673 GBP2023-09-30
Creditors
Amounts falling due within one year
-22,114 GBP2024-09-30
-16,115 GBP2023-09-30
Net Current Assets/Liabilities
31,931 GBP2024-09-30
31,558 GBP2023-09-30
Total Assets Less Current Liabilities
31,931 GBP2024-09-30
31,558 GBP2023-09-30
Net Assets/Liabilities
31,931 GBP2024-09-30
31,558 GBP2023-09-30
Equity
Called up share capital
100 GBP2024-09-30
100 GBP2023-09-30
Retained earnings (accumulated losses)
31,831 GBP2024-09-30
31,458 GBP2023-09-30
Equity
31,931 GBP2024-09-30
31,558 GBP2023-09-30
Average Number of Employees
22023-10-01 ~ 2024-09-30
02022-10-01 ~ 2023-09-30
Number of shares allotted
Class 1 ordinary share
100 shares2023-10-01 ~ 2024-09-30

  • PHARMEDAS CLINICAL LTD
    Info
    PHARMEDAS CLINCAL LTD - 2021-05-31
    Registered number 12195179
    icon of address438 Streatham High Road, London SW16 3PX
    PRIVATE LIMITED COMPANY incorporated on 2019-09-09 (6 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.